1
Asiatic Health News Efficacy of esomeprazole for preventing relapses in patients with healed esophagitis The new proton pump inhibitor Esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive esophagitis BACKGROUND: Esomeprazole, the S-isomer of Omeprazole, is the first proton pump inhibitor to be developed as an optical isomer. In patients with erosive esophagitis, Esomeprazole has produced significantly greater healing rates and improved symptom resolution. METHODS: In this 6-month US multicentre randomized double-blind placebo-controlled trial, 375 Helicobacter pylori-negative patients with Endoscopically healed Esophagitis received Esomeprazole 20 mg or placebo once daily. RESULTS: Significantly more patients remained healed with Esomeprazole 20 mg (80.00 %) than with placebo (30.00 %). Sustained resolution of heartburn was observed in 20 mg groups; there was a high correlation between absence of heartburn and maintenance of healing. CONCLUSIONS: Esomeprazole is effective and well-tolerated in the maintenance of healing of erosive Esophagitis. Esomeprazole 20 mg offer significant clinical benefit to patients. Ref: 1. Aliment Pharmacol Ther. 2001 Jul;15(7):927-35. April 7, 2013 Flupentixol BP 0.5 mg + Melitracen INN 10 mg A new dimension for treating Anxiety and Depression 80 % 30 % Esomeprazole Placebo Healing Rate Courtesy By

Asiatic health news 07.04.13

Embed Size (px)

DESCRIPTION

 

Citation preview

Page 1: Asiatic health news 07.04.13

Asiatic Health NewsEfficacy of esomeprazole for preventing relapses in patients with healed esophagitis

The new proton pump inhibitor Esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive esophagitis

BACKGROUND:Esomeprazole, the S-isomer of Omeprazole, is the first proton pump inhibitor to be developed as an optical isomer. In patients with erosive esophagitis, Esomeprazole has produced significantly greater healing rates and improved symptom resolution.

METHODS:In this 6-month US multicentre randomized double-blind placebo-controlled trial, 375 Helicobacter pylori-negative patients with Endoscopically healed Esophagitis received Esomeprazole 20 mg or placebo once daily.

RESULTS:Significantly more patients remained healed with Esomeprazole 20 mg (80.00 %) than with placebo (30.00 %). Sustained resolution of heartburn was observed in 20 mg groups; there was a high correlation between absence of heartburn and maintenance of healing.

CONCLUSIONS:Esomeprazole is effective and well-tolerated in the maintenance of healing of erosive Esophagitis. Esomeprazole 20 mg offer significant clinical benefit to patients.

Ref

: 1. A

limen

t Pha

rmac

ol T

her.

2001

Jul

;15(

7):9

27-3

5.

April 7, 2013

Flupentixol BP 0.5 mg + Melitracen INN 10 mgA new dimension for treating

Anxiety and Depression

80 %

30 %

Esomeprazole PlaceboHealing Rate

Courtesy By